정예 바이오테크놀로지 홀딩(ZYBT)는 NAS에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $1.37 (+0.00%), 시가총액 $42.08M, 52주 범위 $0.71 ~ $12.67.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China.
정예 바이오테크놀로지 홀딩의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
정예 바이오테크놀로지 홀딩의 현재 주가는 $1.37 (+0.00%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
정예 바이오테크놀로지 홀딩의 시가총액은 약 $42.08M입니다.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.